Personal information

Other IDs

Loop profile: 2368495
ResearcherID: Z-3450-2019

Countries

Denmark

Activities

Collapse all

Employment (2)

Psychiatric Center Copenhagen, Rigshospitalet: Copenhagen, DK

2022-06-01 to present | Postdoc (Research Unit)
Employment
Source: Self-asserted source
Mette Kruse Klausen

Region Hovedstaden: Copenhagen, DK

2016-11-01 to 2021-07-01 | MD, PhD-student (Psychiatric Center Copenhagen, Rigshospitalet)
Employment
Source: Self-asserted source
Mette Kruse Klausen

Education and qualifications (2)

University of Copenhagen: Copenhagen, DK

2022-04-08 | PhD
Education
Source: Self-asserted source
Mette Kruse Klausen

University of Copenhagen: Copenhagen, DK

2011-06-16 | Medical Doctor
Education
Source: Self-asserted source
Mette Kruse Klausen

Professional activities (1)

Frontiers in Behavioral Neuroscience: -, US

2024-08-01 to present | Review editor for Motivation and Reward
Service
Source: Self-asserted source
Mette Kruse Klausen

Works (9)

Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)

BMJ Open
2025 | Journal article
DOI: 10.1136/BMJOPEN-2024-086454
WOSUID: WOS:001396073800001
Contributors: Klausen, Mette Kruse; Kuzey, Tugba; Pedersen, Julie Niemann; Justesen, Signe Keller; Rasmussen, Line; Knorr, Ulla B.; Mason, Graeme; Ekstrom, Claus Thorn; Holst, Jens Juul; Koob, George et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder

Basic & Clinical Pharmacology & Toxicology
2025-03 | Journal article
DOI: 10.1111/bcpt.70004
Contributors: Mette Kruse Klausen; Gitte Moos Knudsen; Tina Vilsbøll; Anders Fink‐Jensen
Source: check_circle
Crossref

Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys

Psychopharmacology
2024 | Journal article
DOI: 10.1007/S00213-024-06637-2
WOSUID: WOS:001248588600001
Contributors: Fink-Jensen, Anders; Wortwein, Gitta; Klausen, Mette Kruse; Holst, Jens Juul; Hartmann, Bolette; Thomsen, Morgan; Ptito, Maurice; Beierschmitt, Amy; Palmour, Roberta M.
Source: check_circle
Web of Science Researcher Profile Sync

The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial

Pilot and Feasibility Studies
2024 | Journal article
DOI: 10.1186/S40814-024-01504-5
WOSUID: WOS:001227199400002
Contributors: Jepsen, Peter; von Wowern, Natasja; Madsen, Lone Galmstrup; Klausen, Mette Kruse; During, Signe; Benthien, Kirstine Skov; Winther-Jensen, Matilde; Petersen, Janne; Askgaard, Gro
Source: check_circle
Web of Science Researcher Profile Sync

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

Nature Medicine
2023-12 | Journal article
DOI: 10.1038/s41591-023-02634-8
Contributors: Lorenzo Leggio; Christian S. Hendershot; Mehdi Farokhnia; Anders Fink-Jensen; Mette Kruse Klausen; Joseph P. Schacht; W. Kyle Simmons
Source: check_circle
Crossref

Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

JCI Insight
2022-09-06 | Journal article
DOI: 10.1172/jci.insight.159863
Contributors: Mette K. Klausen; Mathias E. Jensen; Marco Møller; Nina le Dous; Anne-Marie Ø Jensen; Victoria A. Zeeman; Claas-Frederik Johannsen; Alycia M. Lee; Gerda K. Thomsen; Julian Macoveanu et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders

British Journal of Pharmacology
2022-02 | Journal article
DOI: 10.1111/bph.15677
Contributors: Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink‐Jensen
Source: check_circle
Crossref

Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

Neurochemistry International
2020-09 | Journal article
DOI: 10.1016/j.neuint.2020.104772
Contributors: Mathias E. Jensen; Aurelio Galli; Morgane Thomsen; Kathrine L. Jensen; Gerda K. Thomsen; Mette K. Klausen; Tina Vilsbøll; Mikkel B. Christensen; Jens J. Holst; Anthony Owens et al.
Source: check_circle
Crossref

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial

BMJ Open
2018 | Journal article
DOI: 10.1136/BMJOPEN-2017-019562
WOSUID: WOS:000446181900020
Contributors: Antonsen, Kerstin K.; Klausen, Mette K.; Brunchmann, Amanda S.; le Dous, Nina; Jensen, Mathias E.; Miskowiak, Kamilla Woznica; Fisher, Patrick M.; Thomsen, Gerda K.; Rindom, Henrik; Fahmy, Thomas P. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Peer review (11 reviews for 8 publications/grants)

Review activity for Acta psychiatrica Scandinavica. (1)
Review activity for Addiction biology. (2)
Review activity for BMJ open. (2)
Review activity for European journal of endocrinology. (1)
Review activity for Frontiers in psychiatry. (2)
Review activity for JAMA : (1)
Review activity for The journal of clinical psychiatry. (1)
Review activity for The New England journal of medicine. (1)
How many people are using ORCID?